Cancer preventia

cancer-free future with cancer risk detection ahead of symptoms

simple • non-invasive • high accuracy

Cancer cells can be difficult to detect, especially in the early stages.

This is because:

Small in Size

Small in Size

Conventional imaging techniques may not be able to identify cancer cells in the early stages due to its small size.

Lack of Symptoms

Lack of Symptoms

In some cases, early stages of cancer may not exhibit noticeable symptoms, leading to delayed diagnosis. 

Similarity to Normal Cells

Similarity to Normal Cells

In the early stages, cancer cells resembles closely to healthy cells, making it challenging to identify.

Limitations of Screening Tests

Limitations of Screening Tests

Some cancers lack reliable and sensitive screening tests, further hindering early detection.

Location

Location

Depending on the location of the tumor, gaining access to assess the cancer cells without invasive procedures is challenging.

Heterogeneity

Heterogeneity

Tumors can contain a mix of cancer cells with various genetic mutations, making it extremely complex to target.

  • shape

    Small in Size

    Conventional imaging techniques may not be able to identify cancer cells in the early stages due to its small size.

  • shape

    Lack of Symptoms

    In some cases, early stages of cancer may not exhibit noticeable symptoms, leading to delayed diagnosis.

  • shape

    Similarity to Normal Cells

    In the early stages, cancer cells resembles closely to healthy cells, making it challenging to identify.

  • shape

    Limitations of Screening Tests

    Some cancers lack reliable and sensitive screening tests, further hindering early detection.

  • shape

    Location

    Depending on the location of the tumor, gaining access to assess the cancer cells without invasive procedures is challenging.

  • shape

    Heterogeneity

    Tumors can contain a mix of cancer cells with various genetic mutations, making it extremely complex to target.

Introducing a breakthrough "biological" Cancer Risk Assessment Test - N-NOSE®

Nematodes-100x100

What is N-Nose®?

N-NOSE® is a potent diagnostic tool that detects the risk of cancer, even at stage 1 or earlier with sensitivity of 86.3%. This allows individuals to take proactive measures at a much earlier stage at a much lower risk.

How does N-Nose® work?

Bodily fluids of cancer patients smell different to those of healthy individuals. With just a drop of urine, N-Nose® test screens the risk for 15 types of cancer using the highly sensitive smelling abilities of nematodes (C. elegans) – a type of microscopic roundworm. 

Nematodes (C. elegans) possess approximately 1,200 olfactory receptor genes, surpassing dogs, enabling them to detect minute odors undetectable by machines.

Healthy Urine Sample

Cancer Patient Sample

Why N-Nose®?

1

Non-invasive

Quick and easy test using a single drop of urine.

2

Accessible

Suitable for every individual aged 16 and above.​

For more information on the N-NOSE® technology: https://hbio.jp/en/dsc/archives1

Advantages of Early Detection of Cancer using

N-NOSE®

Increases Range of Treatment Options

Higher Success Rate of Treatment

Improves Recovery Time

Reduces Treatment Expenses

Testimonials

Book for your test now

Frequently Asked Questions

  1. Purchase N-NOSE® online/walk-in.​ 
  2. Make an appointment for urine collection.​ 
  3. Fast for a minimum of 4 hours.​ 
  4. Drop by LifeCare for urine sample.​
  5. Collect only mid-stream urine.​ 
  6. Urine sample delivered to Japan.​ 
  7. Processing time: 6 weeks.​
  8. Receive results & consultations.
  1. Oral/ Pharyngeal
  2. Lung
  3. Breast
  4. Esophageal
  5. Liver
  6. Stomach
  7. Bile Duct
  8. Gall Bladder
  9. Pancreatic
  10. Kidney
  11. Colorectal 
  12. Ovarian
  13. Bladder
  14. Uterine
  15. Prostate

N-NOSE® is a highly sensitive test, similar to other screening tests. Please avoid taking the test if you are not feeling well, extremely tired, not well-rested, pregnant, or having menstruation. For better results, please reschedule your urine collection for another day.

N-NOSE® detects early-stage cancer risks that other tests or screenings may not pick up. Therefore, it is recommended that you repeat the test every 6 months, along with annual comprehensive health screening, to detect the type, location, and progression of any potential cancer as early as possible.

N-NOSE® is a primary screening test for the risk of 15 types of cancer. We recommend that you take N-NOSE® regularly, along with annual comprehensive health screening, especially if you have a family history of cancers or experience any worrisome symptoms on a long-term basis. 

The accuracy of cancer screening tests can be influenced by factors such as the stage of the cancer, the presence of other health conditions, and the test method used. Blood cancer screening tests are not 100% accurate and cannot be used as standalone diagnostic tools. They are used in conjunction with other diagnostic methods and clinical assessments. The results are reviewed by experienced health screening doctors to arrive at a comprehensive diagnosis. 

Congratulations on maintaining good health! Remember, health maintenance is a marathon, and it's important to keep up with healthy lifestyle and dietary habits. While your risk may currently be at A-C, it's essential to stay proactive about your well-being. Performing regular health checks will help you monitor your health and ensure early detection of any potential issues. 

Currently, clinical research on young adults under the age of 16 is ongoing. As a result, clinical data for test efficacy in this age group is not yet available. Therefore, the test is not recommended for individuals below the age of 16 at this time.  

0